《港股開市》恆指高開56點 藥明系急漲 藥明生物飆升15%
市場觀望美國通脹數據,道指升170點或0.5%。港股早市隨外圍高開。恆指高開56點或0.4%,報16,154點;國指高開13點或0.2%,報5,434點;恆生科技指數高開6點或0.2%,報3,434點。
藥明生物(02269.HK)料愛爾蘭基地提前於今年實現盈虧平衡,今年新增專案目標由80個升至110個,股價高開15%報32.2元。藥明康德(02359.HK)每股作價83.25元,涉資12.9億元。該股高開5.5%報78.1元。報道指海底撈(06862.HK)元旦三天假期接待顧客人次按年升70%,該股昨日(10日)炒升逾8%,早市回吐0.8%報14.32元。
科技股方面,阿里(09988.HK)及騰訊(00700.HK)高開0.1%。美團(03690.HK)首度回購涉資4億元,股價高開1.3%報72.65元,京東(09618.HK)高開0.9%。小米(01810.HK)平開報14.1元,百度(09888.HK)、網易(09999.HK)及快手(01024.HK)低開0.6%至0.9%。
車股吉利(00175.HK)、理想(02015.HK)及小鵬(09868.HK)高開0.6%至0.8%,比亞迪(01211.HK)高開1.7%報208元。金融股方面,匯控(00005.HK)低開0.2%,港交所(00388.HK)高開0.2%,友邦(01299.HK)平開報62.45元。其他股份方面,萬洲(00288.HK)高開3.8%。海爾智家(06690.HK)、申洲(02313.HK)及石藥(01093.HK)高開1.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.